Navigation Links
Gilead Sciences Supports HarborPath's HIV/AIDS Medication Assistance Pilot Program
Date:4/24/2013

COLUMBIA, S.C., April 24, 2013 /PRNewswire/ -- HarborPath, an organization which provides a single point of access to HIV/AIDS medications through patient assistance programs, welcomes Gilead Sciences as a participating company. Gilead joins Merck and ViiV Healthcare as the third pharmaceutical company to support HarborPath since its launch in July 2012.

"With Gilead's support of this pilot program, we can extend the reach of the organization and offer access to a broader-range of HIV/AIDS medications," said Ken Trogdon, Jr. , President of HarborPath. "We are thankful for the support of our pharmaceutical company partners and we urge others to join our efforts to serve individuals who need access to medications through patient assistance programs. These programs are a safety net for those who cannot afford their medications and they provide access to the life-saving drugs that allow people living with HIV/AIDS to live longer and healthier lives."

HarborPath is currently piloting the program in six states and Washington, D.C., having most recently added a clinic in South Carolina. HarborPath provides a streamlined process for healthcare professionals and case managers to connect individuals living with HIV/AIDS to multiple patient assistance programs using the common application form on the HarborPath website. The donated medications are delivered at no cost to qualified individuals through HarborPath's contracted mail-order pharmacy.  

"Access to medicines should never be a barrier to care, and I'm encouraged by HarborPath's efforts to ensure streamlined access to life-saving medications for people living with HIV/AIDS," said Congresswoman Barbara Lee of California, Co-Chair of the Congressional HIV/AIDS Caucus. "All stakeholders, including the government, private sector, faith communities, and the philanthropic community have an important role to play to ensure HIV/AIDS medications reach those who need them."

About HarborPath

HarborPath is a 501(c) (3) organization whose mission is to provide streamlined access to HIV/AIDS medications through patient assistance programs via an online portal. For more information, visit www.harborpath.org.


'/>"/>
SOURCE HarborPath
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ePharmaSolutions Wins Major Award for Life Sciences Industry Innovation
2. USANA Health Sciences Now Offering Prenatal Product
3. Chipscreen Biosciences Announces Achievement of Primary Endpoint in Chidamide Registrational Trial in China
4. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
5. Antigen Laboratories, Inc. to be Acquired by Ares Life Sciences
6. Moravia Provides Guidance to Life Sciences Sector as Croatia Nears EU Accession and European Medicines Agency Deadlines Loom
7. Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
8. GlaxoSmithKline and A*STARs Institute of Chemical Engineering and Sciences to Develop new Medicines for Emerging Markets
9. Xenon Named Life Sciences Company of the Year by LifeSciences British Columbia
10. VG Life Sciences Reports Positive Safety Results from Second Cohort Enrollment in Solid Tumor Clinical Trial
11. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Company,s consumer product development program, based ... the Society for Investigative Dermatology (SID) 76 th ... advance and promote the sciences relevant to skin ...
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... name the Creator responds to and which He does not. Yisrayl says with so ... one is the true name, but he says with a little Scripture, backed with a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA ... region. Côté has 20+ years of experience within the beauty industry, ranging from ... an array of high-end cosmetic brands, retail brands and outlets in Canada and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. ... alliance with B. Braun Medical Inc. , a leader in infusion therapy and ... with as many as 90 percent of hospital patients receiving a peripheral IV catheter ...
Breaking Medicine News(10 mins):